Glasgow, United Kingdom

ESTRO 2024

Session

Monday
May 06
08:45 - 10:00
Lomond Auditorium
High-risk non melanoma skin cancer
Jerome Doyen, France;
Romaana Mir, United Kingdom
This clinical skin cancer symposium presents evidence-based guidance for the management of high-risk non-melanoma skin cancer with examination of decision making strategies utilised in the clinic, along with review of the impact of novel genomic staging compared to currently available guidance. High-risk non-melanoma skin cancers develop the older patient population and strategies to measure the cosmetic and quality of life effects of treatment are described, sharing these tools enables radiation oncologists to help patients make informed decisions regarding their care.
3090
Symposium
Clinical
08:45 - 09:03
Overview of guidance and recommendations for skin radiotherapy
Artur Chyrek, Poland
09:03 - 09:21
Decision-making among experts in radiotherapy for NMSC
Paul Martin Putora, Switzerland
09:21 - 09:39
Postoperative radiotherapy in high-risk and advanced NMSC
Nikhil Joshi, USA
09:39 - 09:57
Quality of life and cosmetic assessment in skin cancer treatment
Vasilis Vasiliou, Cyprus